The agreement was signed by state secretary László György on behalf of the ministry, Béla Merkely, the university's rector, and Matt Zeller, managing director of Novartis Hungaria.
As a first pillar, the signatories want to increase access to clinical research at the university and the role of technological-digital innovations in clinical research.
In the second pillar, the signatories aim to ensure Hungary's leading role in cell and gene therapies.
As one of Europe's leading gene therapy centers, the university is helping to launch a national pilot program for neonatal screening of spinal muscular atrophy (SMA). In addition, in the field of ophthalmology, screening for hereditary retinal diseases is being extended.
The third pillar of the cooperation is a cardiovascular public health program affecting 50,000 people, using innovative data analysis and artificial intelligence solutions.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
